Public Sector Pension Investment Board (PSP Investments)’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,040
Closed -$3.17M 1400
2021
Q4
$3.17M Buy
8,040
+4,600
+134% +$1.94M 0.02% 832
2021
Q3
$1.54M Buy
+3,440
New +$1.23M 0.01% 1197
2020
Q1
Sell
-6,379
Closed -$2.63M 1338
2019
Q4
$2.63M Buy
+6,379
New +$2.2M 0.02% 981

Other funds holding ATRA

Public Sector Pension Investment Board (PSP Investments)'s ATRA Position: Q1 2022 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Atara Biotherapeutics (ATRA) in Q1 2022, closing a stake of 8,040 shares — an estimated $3.17M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in ATRA in Q4 2019 and held it in 3 quarters. The position peaked at $3.17M in Q4 2021. 144 funds tracked by Wall St. Rank hold ATRA as of Q1 2022.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Atara Biotherapeutics position as of Q1 2022 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 8,040 Atara Biotherapeutics shares in Q1 2022, an estimated $3.17M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Atara Biotherapeutics in Q4 2019 and held it in 3 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Atara Biotherapeutics position peaked at $3.17M in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2022.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2022, filed 13 May 2022.